Pakistan Following Foot Prints of Developed World in Structural Interventions: Experience of Transcatheter Aortic Valve Implantation Reported First Time.

aortic valve stenosis atrioventricular block bicuspid aortic valve heart valve diseases transcatheter aortic valve replacement

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
16 Nov 2020
Historique:
entrez: 23 12 2020
pubmed: 24 12 2020
medline: 24 12 2020
Statut: epublish

Résumé

Background The aim of this study was to evaluate the safety and efficacy of transcatheter aortic valve implantation (TAVI) program in a Tertiary care hospital in Karachi, Pakistan. Methodology This study was conducted by interventional cardiology department of the National Institute of Cardiovascular Diseases (NICVD), Karachi from July 2015 to February 2020. All patients of severe aortic stenosis (AS) who underwent TAVI were included. Baseline characteristics, in-hospital course and one-month follow-up data were collected. Results This study included 100 consecutive patients with severe AS undergoing TAVI. Sixty-three (63.0%) patients were males and the mean age was 67.38 ± 10.73 years. Eighty-five (85%) patients were in the New York Heart Association (NYHA) class III-IV. Aortic valve mean gradient was 51.33±10.47 mmHg and 50% of patients had bicuspid aortic valves. Core valve was implanted in 86 (86%) and evolute-R aortic valve was implanted in 14 (14%) patients. TAVI was successfully done in 94% of patients. Post-deployment aortic valve mean gradient was 5.33±4.13 mmHg. Major vascular access site complications were noted in 14% and atrioventricular (AV) blocks were seen in 22% of cases. There was a significant difference in symptoms of patients before and after the procedure. Overall, eight (8%) patients expired during hospital stay. At one-month follow-up, 76% of patients were found to have no limitation of physical activities. Conclusions Results of this study showed that TAVI is a safe procedure in these high-risk patients and is an alternative to surgery for AS patients in the region.

Identifiants

pubmed: 33354443
doi: 10.7759/cureus.11497
pmc: PMC7744204
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e11497

Informations de copyright

Copyright © 2020, Ammar et al.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

N Engl J Med. 2005 Jun 9;352(23):2389-97
pubmed: 15944423
Med Biol Eng Comput. 2020 Apr;58(4):815-829
pubmed: 32026185
Ont Health Technol Assess Ser. 2012;12(14):1-62
pubmed: 23074424
N Engl J Med. 2012 May 3;366(18):1705-15
pubmed: 22551129
Eur Heart J. 2014 Jun 21;35(24):1588-98
pubmed: 24022003
J Geriatr Cardiol. 2014 Jun;11(2):163-70
pubmed: 25009568
Heart. 2012 Nov;98 Suppl 4:iv23-9
pubmed: 23143122
Sci Rep. 2019 Nov 19;9(1):17098
pubmed: 31745198
J Am Heart Assoc. 2017 Oct 17;6(10):
pubmed: 29042426
Lancet. 2009 Mar 14;373(9667):956-66
pubmed: 19232707
Ann Cardiol Angeiol (Paris). 2019 Dec;68(6):450-452
pubmed: 31718785
Interv Cardiol. 2017 May;12(1):44-50
pubmed: 29588730
J Am Coll Cardiol. 2016 Sep 13;68(11):1195-1205
pubmed: 27609682
Ann Cardiothorac Surg. 2017 Sep;6(5):516-523
pubmed: 29062748
N Engl J Med. 2011 Jun 9;364(23):2187-98
pubmed: 21639811
Int J Cardiol. 2020 Jan 1;298:83-84
pubmed: 31629565
J Am Coll Cardiol. 2017 May 30;69(21):2579-2589
pubmed: 28330793
Ann Cardiothorac Surg. 2017 Sep;6(5):432-443
pubmed: 29062738
Catheter Cardiovasc Interv. 2009 Oct 1;74(4):634-41
pubmed: 19626687
N Engl J Med. 2014 May 8;370(19):1790-8
pubmed: 24678937
Am J Cardiovasc Dis. 2011;1(3):312-20
pubmed: 22254207
Turk Kardiyol Dern Ars. 2016 Dec;44(8):663-669
pubmed: 28045412
Postepy Kardiol Interwencyjnej. 2017;13(1):10-17
pubmed: 28344612
J Am Coll Cardiol. 2013 Sep 10;62(11):1002-12
pubmed: 23727214
Prog Cardiovasc Dis. 2014 May-Jun;56(6):565-71
pubmed: 24838132
Eur J Prev Cardiol. 2018 Apr;25(6):608-617
pubmed: 29473424
Circulation. 2011 Jul 26;124(4):425-33
pubmed: 21747054
Indian Heart J. 2016 Sep - Oct;68(5):732-736
pubmed: 27773417

Auteurs

Ali Ammar (A)

Adult Cardiology, National Institute of Cardiovascular Diseases, Karachi, PAK.

Syed N Hassan Rizvi (SN)

Interventional Cardiology, National Institute of Cardiovascular Diseases, Karachi, PAK.

Tahir Saghir (T)

Interventional Cardiology, National Institute of Cardiovascular Diseases, Karachi, PAK.

Naveedullah Khan (N)

Interventional Cardiology, National Institute of Cardiovascular Diseases, Karachi, PAK.

Parveen Akhtar (P)

Cardiology, National Institute of Cardiovascular Diseases, Karachi, PAK.

Naeem Mengal (N)

Cardiology/Interventional Cardiology, National Institute of Cardiovascular Diseases, Karachi, PAK.

Jawaid A Sial (JA)

Cardiology, National Institute of Cardiovascular Diseases, Karachi, PAK.

Nadeem Qamar (N)

Cardiology, National Institute of Cardiovascular Diseases, Karachi, PAK.

Classifications MeSH